Evaluation of Time in Therapeutic Range on Warfarin Therapy Between Face-to-Face and Telephone Follow-Up in a VA Medical Center
- 1 October 2014
- journal article
- research article
- Published by SAGE Publications in Journal of Pharmacy Technology
- Vol. 31 (2) , 78-83
Abstract
Background: Few studies have evaluated percent time in therapeutic range (TTR) for warfarin managed via face-to-face (FF) to telephone (TELE) visits—all finding no difference between groups. Objective: Compare and evaluate TTR for warfarin in patients who received pharmacist-managed care via FF or TELE. Methods: Single-center, retrospective study. Eligible participants were ≥18 years old, on indefinite warfarin therapy, followed by clinical pharmacists via FF or TELE from 2010 to 2012. Primary outcome (TTR) calculated via Rosendaal method. Event data included rates of any bleeding, significant bleeding, deep vein thrombosis, pulmonary embolism, cerebrovascular accident, hospitalizations, and death. Clinics were also compared by location. Results: Two hundred subjects (90 FF and 110 TELE) were included. Mean TTR was 68.17% and 69.57% in FF and TELE groups, respectively. The FF group had statistically significant higher rates of any bleeding (48.9% vs 30.9%). Rates of significant bleeding in FF versus TELE were not significantly different (6.67% vs 2.73%). The majority followed FF with significant bleeding were at a higher bleeding risk than those followed via TELE. There were low rates of venous thromboembolism (1.1% and 1.8%). Conclusions: TTR was ≥65% for most subjects with minimal variability in TTR between clinics. Mean TTR results for each group were greater and above the threshold that has been commonly described in the literature as quality control, suggesting a progression in implementation of telephone-based anticoagulation management.Keywords
This publication has 18 references indexed in Scilit:
- Telephone-based anticoagulation management in the homebound setting: a retrospective observational studyInternational Journal of General Medicine, 2013
- Oral Anticoagulant TherapyChest, 2012
- Risk-Adjusted Percent Time in Therapeutic Range as a Quality Indicator for Outpatient Oral AnticoagulationCirculation: Cardiovascular Quality and Outcomes, 2011
- Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic RangeCirculation, 2008
- Comparison of Outcomes Among Patients Randomized to Warfarin Therapy According to Anticoagulant ControlArchives of internal medicine (1960), 2007
- Outcomes of Oral Anticoagulant Therapy Managed by Telephone vs In-Office Visits in an Anticoagulation Clinic SettingChest, 2006
- Effect of a Centralized Clinical Pharmacy Anticoagulation Service on the Outcomes of Anticoagulation TherapyChest, 2005
- Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. a retrospective study of 2300 consecutive patients with venous thromboembolismBritish Journal of Haematology, 2005
- Telephone consultationsBMJ, 2003
- Patient and physician satisfaction with a telephone-based anticoagulation serviceJournal of General Internal Medicine, 2001